# Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment

> **NCT06855433** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 150 (estimated)

## Conditions studied

- CPPD - Calcium Pyrophosphate Deposition Disease

## Interventions

- **DRUG:** Colchicine Pill
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06855433
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2029-09-01
- **Final completion:** 2029-10-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06855433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06855433, "Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06855433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*